Boston Scientific BSX EBIT

EBIT at other companies

AbbottABT

$1.69B-17.5%

TFX

TeleflexTFX

$20.18M-73.4%

Johnson & JohnsonJNJ

$7.14B+7.4%

StrykerSYK

$1.66B+49.1%

HaemoneticsHAE

$67.4M+14.2%

CONMEDCNMD

$36.41M-4.6%

FAQ

What is Boston Scientific's EBIT?

Boston Scientific (BSX) reported EBIT of $1.18B in Q2 2026.

How has Boston Scientific's EBIT changed year-over-year?

Boston Scientific's EBIT increased by 43.8% year-over-year, from $819M to $1.18B.

What is the long-term trend for Boston Scientific's EBIT?

Over 4 years (2021 to 2025), Boston Scientific's EBIT has grown at a 31.8% compound annual growth rate (CAGR), from $1.2B to $3.61B.

What does EBIT mean?

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.